Prange Karen (CIK 1566083) reported 9 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy OM (10,667 shares), Sell ATRC (3,000 shares), Buy ATRC (6,144 shares), Buy EMBC (22,841 shares), Buy OM (18,667 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Outset Medical, Inc. (OM) | Director | Buy | 10,667 | $0 |
| 2026-05-22 | AtriCure, Inc. (ATRC) | Director | Sell | 3,000 | $85,950 |
| 2026-05-20 | AtriCure, Inc. (ATRC) | Director | Buy | 6,144 | $0 |
| 2026-02-13 | Embecta Corp. (EMBC) | Director | Buy | 22,841 | $0 |
| 2026-01-12 | Outset Medical, Inc. (OM) | Director | Buy | 18,667 | $0 |
| 2025-05-21 | AtriCure, Inc. (ATRC) | Director | Buy | 5,401 | $0 |
| 2025-04-03 | NEVRO CORP (NVRO) | Director | Sell | 33,948 | $0 |
| 2025-03-07 | AtriCure, Inc. (ATRC) | Director | Sell | 6,100 | $232,532 |
| 2025-02-14 | Embecta Corp. (EMBC) | Director | Buy | 13,839 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05